Mechelen
Belgium
127
2023-10-05
117
2025-11-18
These are the the leading inventors for applications assigned to GALAPAGOS N.V.:
GALAPAGOS N.V. based in Mechelen, BE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS
#2 | 2023-01-26NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS
#3 | 2022-12-22 ✅ Patent 12,264,156 granted on 2025-04-01Compounds and pharmaceutical compositions thereof for the treatment of diseases
#4 | 2022-10-27 ✅ Patent 12,065,443 granted on 2024-08-20Compounds and pharmaceutical compositions thereof for the treatment of diseases
#5 | 2022-07-21NOVEL DIHYDROPYRIMIDINOISOQUINOLINONES AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS.
#6 | 2022-06-30 ✅ Patent 12,383,544 granted on 2025-08-12NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF KIDNEY DISEASES
#7 | 2021-11-18 ✅ Patent 11,975,008 granted on 2024-05-07Pharmaceutical compositions comprising a JAK inhibitor
#8 | 2021-10-07 ✅ Patent 11,718,588 granted on 2023-08-085-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis
#9 | 2021-09-02 ✅ Patent 11,667,633 granted on 2023-06-06Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
#10 | 2021-06-10 ✅ Patent 11,564,923 granted on 2023-01-31Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
#11 | 2021-04-08 ✅ Patent 11,339,166 granted on 2022-05-24Compounds and pharmaceutical compositions thereof for the treatment of diseases
#12 | 2020-12-03 ✅ Patent 11,345,691 granted on 2022-05-31Prodrug modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
#13 | 2020-09-03 ✅ Patent 10,981,890 granted on 2021-04-20Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
#14 | 2020-09-03 ✅ Patent 10,829,473 granted on 2020-11-10Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
#15 | 2020-09-03 ✅ Patent 10,844,042 granted on 2020-11-24Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
#16 | 2020-09-03 ✅ Patent 10,844,041 granted on 2020-11-24Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
#17 | 2020-07-30 ✅ Patent 10,919,890 granted on 2021-02-16Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
#18 | 2020-07-30 ✅ Patent 11,072,611 granted on 2021-07-27Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
#19 | 2020-07-09 ✅ Patent 11,987,621 granted on 2024-05-21Antibodies for IL-17C
#20 | 2020-07-09 ✅ Patent 10,941,117 granted on 2021-03-095-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis
#21 | 2020-05-28 ✅ Patent 11,136,325 granted on 2021-10-05Pyrrolopyrimidine and pyrrolopyridine derivatives
#22 | 2020-04-23DEUTERATED CFTR MODULATORS AND METHODS OF USE
#23 | 2020-03-12 ✅ Patent 11,000,528 granted on 2021-05-11Compound useful for the treatment of degenerative and inflammatory diseases
#24 | 2019-10-31 ✅ Patent 10,647,717 granted on 2020-05-12N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
#25 | 2019-10-17 ✅ Patent 10,829,478 granted on 2020-11-105-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating e.g. osteoarthritis
#26 | 2019-10-03 ✅ Patent 10,550,100 granted on 2020-02-045-[3-[piperzin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating E.G. osteoarthritis
#27 | 2019-07-04 ✅ Patent 10,633,439 granted on 2020-04-28Antibodies for IL-17C
#28 | 2019-06-06 ✅ Patent 10,526,329 granted on 2020-01-07Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
#29 | 2019-03-14 ✅ Patent 10,988,454 granted on 2021-04-27Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
#30 | 2019-02-28 ✅ Patent 10,815,297 granted on 2020-10-27Antagonists of IL17C for the treatment of inflammatory disorders
#31 | 2019-02-28 ✅ Patent 10,568,879 granted on 2020-02-25Dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
#32 | 2019-02-21 ✅ Patent 10,604,515 granted on 2020-03-31Heteroaryl substituted pyridines and methods of use
#33 | 2019-02-14ANTIBODIES FOR IL-17C
#34 | 2019-01-03 ✅ Patent 11,220,499 granted on 2022-01-11Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
#35 | 2018-11-29 ✅ Patent 10,259,869 granted on 2019-04-16Antibodies for IL-17C
#36 | 2018-10-25 ✅ Patent 10,508,111 granted on 2019-12-176-[5-amino-6-(2-ethoxyethoxy)-imidazo[4,5-B]pyridin-3-yl]-nicotinonitrile derivatives and their use as IRAK inhibitors
#37 | 2018-09-27 ✅ Patent 10,604,566 granted on 2020-03-31Antagonists of IL-17C for the treatment and/or prevention of atopic dermatitis
#38 | 2018-09-13 ✅ Patent 10,487,060 granted on 2019-11-265-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis
#39 | 2018-08-30 ✅ Patent 10,428,017 granted on 2019-10-01Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
#40 | 2018-08-09 ✅ Patent 10,568,867 granted on 2020-02-25Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
#41 | 2018-07-05 ✅ Patent 10,376,520 granted on 2019-08-13Methods for the treatment of cardiovascular disorders
#42 | 2018-05-10NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS
#43 | 2018-04-19 ✅ Patent 10,259,810 granted on 2019-04-16N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
#44 | 2018-04-12 ✅ Patent 10,399,940 granted on 2019-09-03Substituted pyrrolidines and methods of use
#45 | 2018-04-12 ✅ Patent 9,981,910 granted on 2018-05-29Substituted pyrrolidines and methods of use
#46 | 2018-02-15 ✅ Patent 10,048,250 granted on 2018-08-14Molecular targets and compounds, and methods to identify the same, useful in the treatment of fibrotic diseases
#47 | 2018-01-18NOVEL DIHYDROPYRIMIDINOISOQUINOLINONES AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS (GPR84 ANTAGONISTS)
#48 | 2018-01-04 ✅ Patent 10,708,263 granted on 2020-07-07Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
#49 | 2018-01-04 ✅ Patent 9,926,281 granted on 2018-03-275-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis
#50 | 2018-01-04 ✅ Patent 10,328,081 granted on 2019-06-25Compound useful for the treatment of degenerative and inflammatory diseases
#51 | 2017-12-21 ✅ Patent 10,125,132 granted on 2018-11-13Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
#52 | 2017-12-07 ✅ Patent 10,138,227 granted on 2018-11-27Heteroaryl substituted pyridines and methods of use
#53 | 2017-10-26 ✅ Patent 10,118,916 granted on 2018-11-06Modulators of cystic fibrosis transmembrane conductance regulator protein
#54 | 2017-04-13 ✅ Patent 9,796,711 granted on 2017-10-24Substituted pyrazolo[3,4-]pyridin-6-carboxylic acids and method of use
#55 | 2017-04-13 ✅ Patent 9,890,158 granted on 2018-02-13N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
#56 | 2017-04-13 ✅ Patent 10,130,622 granted on 2018-11-20Compounds for treatment of cystic fibrosis
#57 | 2017-03-02 ✅ Patent 10,179,771 granted on 2019-01-15Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
#58 | 2017-02-09 ✅ Patent 10,206,907 granted on 2019-02-19Compounds useful for the treatment of degenerative and inflammatory diseases
#59 | 2017-01-19 ✅ Patent 9,840,513 granted on 2017-12-12Substituted tricyclics and method of use
#60 | 2016-12-08 ✅ Patent 10,047,051 granted on 2018-08-14Substituted pyridines and method of use
#61 | 2016-11-03 ✅ Patent 9,895,347 granted on 2018-02-20Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
#62 | 2016-10-13 ✅ Patent 9,707,237 granted on 2017-07-18Compound useful for the treatment of degenerative and inflammatory diseases
#63 | 2016-09-15 ✅ Patent 9,867,806 granted on 2018-01-16Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
#64 | 2016-08-25 ✅ Patent 9,670,204 granted on 2017-06-06Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
#65 | 2016-08-25 ✅ Patent 10,047,083 granted on 2018-08-14Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
#66 | 2016-07-28 ✅ Patent 9,796,719 granted on 2017-10-24Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
#67 | 2016-07-28 ✅ Patent 9,987,272 granted on 2018-06-05Compound useful for the treatement of degenerative and inflammatory diseases
#68 | 2016-07-21 ✅ Patent 9,951,337 granted on 2018-04-24Methods and means for treatment of osteoarthritis
#69 | 2016-05-05 ✅ Patent 9,567,322 granted on 2017-02-14Substituted tetrahydropyrans and method of use
#70 | 2016-05-05 ✅ Patent 9,642,831 granted on 2017-05-09Substituted chromanes and method of use
#71 | 2016-03-10 ✅ Patent 9,952,202 granted on 2018-04-24Methods of identifying compounds for the treatment of fibrosis by using S1PR5
#72 | 2016-02-11 ✅ Patent 9,708,312 granted on 2017-07-18Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders (GPR84 antagonists)
#73 | 2016-01-28 ✅ Patent 9,351,955 granted on 2016-05-31Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
#74 | 2015-11-19 ✅ Patent 9,945,843 granted on 2018-04-17Methods for identifying compounds that inhibit G protein-coupled receptor (GPR84) agonist-stimulated chemotaxis
#75 | 2015-10-01 ✅ Patent 9,309,244 granted on 2016-04-12Compound useful for the treatment of degenerative and inflammatory diseases
#76 | 2015-08-13 ✅ Patent 9,382,247 granted on 2016-07-05Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
#77 | 2015-08-13 ✅ Patent 10,493,158 granted on 2019-12-03Pharmaceutical compositions for the treatment of inflammatory disorders
#78 | 2015-07-23 ✅ Patent 9,440,929 granted on 2016-09-13Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
#79 | 2015-06-04 ✅ Patent 9,415,037 granted on 2016-08-16Compounds useful for the treatment of degenerative and inflammatory diseases
#80 | 2015-04-23 ✅ Patent 9,249,141 granted on 2016-02-02Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
#81 | 2015-03-19 ✅ Patent 9,062,051 granted on 2015-06-23Compounds and pharmaceutical compositions thereof for the treatment of proliferative disorders
#82 | 2015-02-12 ✅ Patent 9,133,210 granted on 2015-09-15Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
#83 | 2015-01-29 ✅ Patent 9,241,931 granted on 2016-01-26Compound useful for the treatment of degenerative and inflammatory diseases
#84 | 2015-01-29 ✅ Patent 9,505,754 granted on 2016-11-29Compound useful for the treatment of degenerative and inflammatory diseases
#85 | 2015-01-01 ✅ Patent 9,382,254 granted on 2016-07-05Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
#86 | 2014-10-09 ✅ Patent 8,993,590 granted on 2015-03-31Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
#87 | 2014-07-31NOVEL COMPOUND USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES
#88 | 2014-05-01 ✅ Patent 9,255,095 granted on 2016-02-09Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
#89 | 2014-04-17METHODS AND MEANS FOR TREATMENT OF OSTEOARTHRITIS
#90 | 2014-04-10 ✅ Patent 8,999,979 granted on 2015-04-07Compound useful for the treatment of degenerative and inflammatory diseases
#91 | 2014-02-20 ✅ Patent 8,975,406 granted on 2015-03-10Compound useful for the treatment of degenerative and inflammatory diseases
#92 | 2013-12-26 ✅ Patent 9,284,311 granted on 2016-03-15Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical compositions thereof
#93 | 2013-11-14 ✅ Patent 8,759,334 granted on 2014-06-24Compounds useful for the treatment of metabolic and inflammatory diseases
#94 | 2013-06-27 ✅ Patent 8,927,543 granted on 2015-01-06Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
#95 | 2013-03-07 ✅ Patent 8,883,425 granted on 2014-11-11Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
#96 | 2012-11-01 ✅ Patent 8,802,682 granted on 2014-08-12Compound useful for the treatment of degenerative and inflammatory diseases
#97 | 2012-07-26 ✅ Patent 8,574,857 granted on 2013-11-05Method and means for treatment of osteoarthritis
#98 | 2012-07-26 ✅ Patent 8,673,268 granted on 2014-03-18Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
#99 | 2012-06-07 ✅ Patent 8,563,545 granted on 2013-10-22Compound useful for the treatment of degenerative and inflammatory diseases
#100 | 2012-05-10 ✅ Patent 8,765,766 granted on 2014-07-01Pyrimidine derivatives which are antagonists of the vitronectin receptor
Also check out GALAPAGOS NV's (Mechelen, Belgium) applicant profile with 80 patent applications submitted.
12926 ⎘